NCT04956887View on ClinicalTrials.gov

Cognitive Training in Survivors of Covid-19: A Randomized Trial

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2024

Conditions
Covid19Cognitive Impairment
Interventions
BEHAVIORAL

AKL-T01

The study intervention, AKL-T01 (Akili Interactive), is a digital, app-based intervention designed to target and improve cognition through an engaging video game-based software experience delivered on an iPad.

OTHER

Control Group

Patients assigned to the control group will receive no intervention, as is typical for those with Covid-19 with respect to cognitive functioning

Trial Locations (1)

37203

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04956887 - Cognitive Training in Survivors of Covid-19: A Randomized Trial | Biotech Hunter | Biotech Hunter